Clinical Application of Circulating Tumor Cells and Circulating Tumor DNA in Uveal Melanoma

PURPOSE: To evaluate the feasibility of using circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) for the management of uveal melanoma (UM). PATIENTS AND METHODS: Low-coverage whole-genome sequencing was used to determine somatic chromosomal copy number alterations (SCNAs) in primary UM...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JCO Precis Oncol
Autors principals: Beasley, Aaron, Isaacs, Timothy, Khattak, Muhammad A., Freeman, James B., Allcock, Richard, Chen, Fred K., Pereira, Michelle R., Yau, Kyle, Bentel, Jaqueline, Vermeulen, Tersia, Calapre, Leslie, Millward, Michael, Ziman, Melanie R., Gray, Elin S.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Clinical Oncology 2018
Matèries:
Original Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7446501/
https://ncbi.nlm.nih.gov/pubmed/32913999
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/PO.17.00279
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars